-
Amedisys to Present at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference
Source: Nasdaq GlobeNewswire / 28 Feb 2022 08:00:01 America/New_York
BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer, will present at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference on Tuesday, March 8, at 11:35 a.m. EST.
To access a live webcast of the Amedisys presentation, please log on through our website at https://investors.amedisys.com.
About Amedisys:
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With ~21,000 employees, in 529 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact:
Nick Muscato
Amedisys, Inc.
Investor Relations
615.928.5452
IR@amedisys.comKendra Kimmons
Amedisys, Inc.
Media Relations
225.299.3720
Kendra.kimmons@amedisys.com